Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 / 抑制剂/激动剂 /
血管生成
蛋白质酪氨酸激酶
/ Src / PP2

PP2 {[allProObj[0].p_purity_real_show]}

货号：A146866

PP2是一种可逆的、ATP竞争性的Src家族激酶抑制剂，对Lck和Fyn的IC50值分别为4 nM和5 nM。

PP2 化学结构 CAS号：172889-27-9
PP2 化学结构
CAS号：172889-27-9
PP2 3D分子结构
CAS号：172889-27-9
PP2 化学结构 CAS号：172889-27-9
PP2 3D分子结构 CAS号：172889-27-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

PP2 纯度/质量文件 产品仅供科研

货号：A146866 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
• JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
• BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
• J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
• PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 Fyn ↓ Lck ↓ Lyn ↓ Src ↓ Yes ↓ 其他靶点 纯度
Saracatinib ++

Fyn, IC50: 10 nM

 		++++

LCK, IC50: <4 nM

 		+++

Lyn, IC50: 5 nM

 		++++

c-Src, IC50: 2.7 nM

 		99%+
SU6656 +

Fyn, IC50: 170 nM

 		+

Lyn, IC50: 130 nM

 		+

Src, IC50: 280 nM

 		++

YES, IC50: 20 nM

 		98%
PP1 +++

Fyn, IC50: 6 nM

 		+++

LCK, IC50: 5 nM

 		EGFR 99%+
PP2 +++

Fyn, IC50: 5 nM

 		++++

LCK, IC50: 4 nM

 		98%
WH-4-023 ++++

Lck, IC50: 2 nM

 		+++

Src, IC50: 6 nM

 		99%+
NVP-BHG 712 +

c-Src, IC50: 1.266 μM

 		99%+
CCT196969 ++

LCK, IC50: 0.02 μM

 		+

Src, IC50: 0.03 μM

 		98%
MNS +

Src, IC50: 29.3 μM

 		p97,Syk 98%
Tirbanibulin ++

Src (Hep 3B), GI50: 26 nM

Src (HuH7), GI50: 13 nM

 		99%+
PP121 ++

Src, IC50: 14 nM

 		VEGFR,PDGFR 99%+
Bosutinib ++++

Src, IC50: 1.2 nM

 		99%
Dasatinib monohydrate ++++

Src, IC50: 0.8 nM

 		98%
Quercetin ✔ Sirtuin,PKC 97%
Dasatinib ++++

Src, IC50: 0.8 nM

 		98%
Repotrectinib +++

Src, IC50: 5.3 nM

 		99%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

PP2 生物活性

靶点

  • Fyn

    Fyn, IC50:5 nM

  • Lck

    LCK, IC50:4 nM
描述 Src and Src-family protein kinases are proto-oncogenes that play key roles in cell morphology, motility, proliferation, and survival[3]. PP2 is a reversible and ATP-competitive Src family kinases inhibitor with IC50s of 4 and 5 nM for Lck and Fyn, respectively[4]. At 10 μM, the effect of PP2 on cellular proliferation is not significant, indicating that, at this low concentration, the effect of PP2 on Gemcitabine cytotoxicity does not simply reflect a direct antiproliferative effect, but rather a potentiation of Gemcitabine-induced cytotoxicity. Above 20 μM, growth is increasingly suppressed, a finding consistent with reports in other human cancer cell lines. The tumor growth inhibition rate is 25% in the PP2 treatment group and 5% in the Gemcitabine treatment group (P>0.05). PP2 is the most widely used commercially available Src family kinase inhibitor. PP2 inhibits Src family kinase activity with IC50 of ~5 nM in vitro, concentrations to 10 μM are often necessary to achieve complete Src family kinase inhibition in cell culture[5].

PP2 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
8701-BC cells 10 μM Function assay Proapoptotic activity against 8701-BC cells at 10 uM by PARP assay 16509573
A431 cells Function assay Inhibitory effect on phospho-Src/nonphospho after EGF (100 uM) stimulation of A431 cells, IC50=17 μM 15109642
A431 cells 10 μM Function assay Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM 16509573
human K562 cells Proliferation assay Antiproliferative activity against human K562 cells, IC50=25 μM 18257513

PP2 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01434472 Post-Transplant Lymphoprolifer... 展开 >>ative Disorder Recurrent Adult Diffuse Large Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma 收起 << Phase 2 Recruiting September 24, 2022 United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-288-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal 收起 <<
NCT00438880 Adult Non-Hodgkin Lymphoma ... 展开 >> Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Nodal Marginal Zone Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia 收起 << Phase 1 Phase 2 Completed - United States, Iowa ... 展开 >> University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00119392 B-cell Chronic Lymphocytic Leu... 展开 >>kemia Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenström Macroglobulinemia 收起 << Phase 2 Completed - United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 <<

PP2 参考文献

[1]Robert Roskoski Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun. 2004. 324(4), 1155-64.

[2]Hanke JH, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependentT cell activation. J Biol Chem. 1996. 271(2), 695-701.

[3]Summy JM, et al. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Mol Cancer Ther. 2005. 4(12), 1900-11.

PP2 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.31mL

0.66mL

0.33mL

16.57mL

3.31mL

1.66mL

33.14mL

6.63mL

3.31mL

PP2 技术信息

CAS号172889-27-9
分子式C15H16ClN5
分子量 301.774
别名
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,Store in freezer, under -20°C
溶解度

DMSO: 50 mg/mL(165.69 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方

IP 2% DMSO+water 0.1 mg/mL clear

PO 0.5% CMC-Na 31 mg/mL suspension

Tags: PP2 | Src | AmBeed-信号通路专用抑制剂 | PP2 纯度/质量文件 | PP2 亚型比较 | PP2 生物活性 | PP2 细胞研究 | PP2 临床数据 | PP2 参考文献 | PP2 实验方案 | PP2 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z